Ohio has added arthritis, chronic migraines, and complex regional pain syndrome to the state’s medical cannabis qualifying list, the Cincinnati Enquirer reports. The decision was made by the State Medical Board of Ohio in February.
The board also last week advanced three more conditions for consideration by the full board at a future meeting: Huntington’s disease, spasticity or persistent muscle spasms, and terminal illness. The committee rejected petitions for panic disorder with agoraphobia, restless leg syndrome, and autism spectrum disorder, the report says.
In approving chronic migraines, the board drew a distinction between the condition and occasional migraines. Board member Dr. Amol Soin explained in February that the intention was not to add patients who have “a migraine once a year and it self-resolves.”
The board has not yet sent the list to the state’s physicians that are registered to recommend medical cannabis, but it will be shared in the monthly newsletter for those physicians, a board spokesperson told the Enquirer. As of May 7, there were 673 physicians registered to make program recommendations, according to the state data.
Last year, the state added cachexia to the qualifying condition list, while rejecting anxiety and autism spectrum disorder. Last month, the board approved a more-than-doubling of the state’s dispensaries from 60 to 130.
There are now 25 qualifying conditions on the state’s qualifying conditions list.
In all, there are 176,387 patients registered with the state program.
Get daily cannabis business news updates. Subscribe